Cover Image
Market Research Report
Product code 
1072553

Asia Pacific Transcriptomics Market Size, Share & Industry Trends Analysis Report By Technology (q PCR, Microarrays, and Sequencing Technology), By Application, By Component, By Country and Growth Forecast, 2021 - 2027

Published: | KBV Research | 102 Pages | Delivery time: 1-2 business days

Price

Back to Top
Asia Pacific Transcriptomics Market Size, Share & Industry Trends Analysis Report By Technology (q PCR, Microarrays, and Sequencing Technology), By Application, By Component, By Country and Growth Forecast, 2021 - 2027
Published: March 31, 2022
KBV Research
Content info: 102 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Asia Pacific Transcriptomics Market would witness market growth of 8.3% CAGR during the forecast period (2021-2027).

Transcriptomics is the exploration of the transcriptome, which is the entire set of RNA transcripts produced by the genome under certain conditions or in a specific cell, utilizing high-throughput technologies like microarray analysis. In addition, genes that are differentially expressed in different cell groups or in response to different treatments can be identified by comparing transcriptomes.

Rising R&D spending in transcriptomic technologies by pharmaceutical and biotechnology companies, as well as increased demand for tailored medication in cancer treatment, are driving the growth of the RNA analysis/transcriptomics market. Additionally, Oxford Brookes University recognized the development of improved single-cell transcriptomic technologies in April 2021. These technologies evaluate several individual cells from living creatures and sequence each cell's genetic material. According to the study, this procedure allows scientists to swap samples between labs, maintain the material, and freeze sample sets to examine at the same time without harming the cell's quality.

Governments and businesses are increasing their funding for biotechnology research in Asia Pacific countries. In addition, the Japanese government and non-government groups are enthusiastic about the advancement of biotechnology research in Japan, and they sponsor research in health and the life sciences. This pushes scientists to go deeper into the transcriptomics field. Furthermore, the increased focus on Asia Pacific nations is likely to give growth prospects for manufacturers due to low-cost manufacturing services. Moreover, the leading players of the regional market have shifted their attention to emerging markets and begun to build a robust position in the market through various strategic efforts, such as acquisitions.

The growing applications of Transcriptomics in Human and pathogen transcriptomes would boost its usage in the regional market. The majority of transcriptomic research has focused on either the host or the pathogen.

The China market dominated the Asia Pacific Transcriptomics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $705.9 million by 2027. The Japan market is anticipated to grow at a CAGR of 7.7% during (2021 - 2027). Additionally, The India market would display a CAGR of 9% during (2021 - 2027).

Based on Technology, the market is segmented into q PCR, Microarrays, and Sequencing Technology. Based on Application, the market is segmented into Drug Discovery, Diagnostics & Disease Profiling, and Others. Based on Component, the market is segmented into Consumables, Instruments, Software, and Services. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Promega Corporation, General Electric (GE) Co., Merck & Co., Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., and Qiagen N.V.

Scope of the Study

Market Segments covered in the Report:

By Technology

  • q PCR
  • Microarrays
  • Sequencing Technology

By Application

  • Drug Discovery
  • Diagnostics & Disease Profiling
  • Others

By Component

  • Consumables
  • Instruments
  • Software
  • Services

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Fluidigm Corporation
  • Promega Corporation
  • General Electric (GE) Co.
  • Merck & Co., Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Transcriptomics Market, by Technology
    • 1.4.2 Asia Pacific Transcriptomics Market, by Application
    • 1.4.3 Asia Pacific Transcriptomics Market, by Component
    • 1.4.4 Asia Pacific Transcriptomics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
    • 3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan - 2021, Apr) Leading Players
    • 3.3.3 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar - 2021, Nov) Leading Players

Chapter 4. Asia Pacific Transcriptomics Market by Technology

  • 4.1 Asia Pacific q PCR Market by Country
  • 4.2 Asia Pacific Microarrays Market by Country
  • 4.3 Asia Pacific Sequencing Technology Market by Country

Chapter 5. Asia Pacific Transcriptomics Market by Application

  • 5.1 Asia Pacific Drug Discovery Market by Country
  • 5.2 Asia Pacific Diagnostics & Disease Profiling Market by Country
  • 5.3 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Transcriptomics Market by Component

  • 6.1 Asia Pacific Consumables Market by Country
  • 6.2 Asia Pacific Instruments Market by Country
  • 6.3 Asia Pacific Software Market by Country
  • 6.4 Asia Pacific Services Market by Country

Chapter 7. Asia Pacific Transcriptomics Market by Country

  • 7.1 China Transcriptomics Market
    • 7.1.1 China Transcriptomics Market by Technology
    • 7.1.2 China Transcriptomics Market by Application
    • 7.1.3 China Transcriptomics Market by Component
  • 7.2 Japan Transcriptomics Market
    • 7.2.1 Japan Transcriptomics Market by Technology
    • 7.2.2 Japan Transcriptomics Market by Application
    • 7.2.3 Japan Transcriptomics Market by Component
  • 7.3 India Transcriptomics Market
    • 7.3.1 India Transcriptomics Market by Technology
    • 7.3.2 India Transcriptomics Market by Application
    • 7.3.3 India Transcriptomics Market by Component
  • 7.4 South Korea Transcriptomics Market
    • 7.4.1 South Korea Transcriptomics Market by Technology
    • 7.4.2 South Korea Transcriptomics Market by Application
    • 7.4.3 South Korea Transcriptomics Market by Component
  • 7.5 Singapore Transcriptomics Market
    • 7.5.1 Singapore Transcriptomics Market by Technology
    • 7.5.2 Singapore Transcriptomics Market by Application
    • 7.5.3 Singapore Transcriptomics Market by Component
  • 7.6 Malaysia Transcriptomics Market
    • 7.6.1 Malaysia Transcriptomics Market by Technology
    • 7.6.2 Malaysia Transcriptomics Market by Application
    • 7.6.3 Malaysia Transcriptomics Market by Component
  • 7.7 Rest of Asia Pacific Transcriptomics Market
    • 7.7.1 Rest of Asia Pacific Transcriptomics Market by Technology
    • 7.7.2 Rest of Asia Pacific Transcriptomics Market by Application
    • 7.7.3 Rest of Asia Pacific Transcriptomics Market by Component

Chapter 8. Company Profiles

  • 8.1 Fluidigm Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Product Launches and Product Expansions:
  • 8.2 Promega Corporation
    • 8.2.1 Company Overview
  • 8.3 General Electric (GE) Co. (GE Healthcare)
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
  • 8.4 Merck & Co., Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
  • 8.5 Thermo Fisher Scientific, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Acquisition and Mergers:
    • 8.5.6 SWOT Analysis
  • 8.6 Illumina, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
  • 8.7 Bio-Rad laboratories, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
      • 8.7.5.2 Product Launches and Product Expansions:
      • 8.7.5.3 Acquisition and Mergers:
  • 8.8 Agilent Technologies, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expense
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Acquisition and Mergers:
  • 8.9 F. Hoffmann-La Roche Ltd.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
  • 8.10. Qiagen N.V.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Partnerships, Collaborations, and Agreements:
      • 8.10.5.2 Product Launches and Product Expansions:
      • 8.10.5.3 Acquisition and Mergers:

LIST OF TABLES

  • TABLE 1 Asia Pacific Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 2 Asia Pacific Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements - Transcriptomics Market
  • TABLE 4 Product Launches And Product Expansions - Transcriptomics Market
  • TABLE 5 Acquisition and Mergers- Transcriptomics Market
  • TABLE 6 Asia Pacific Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 7 Asia Pacific Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 8 Asia Pacific q PCR Market by Country, 2017 - 2020, USD Million
  • TABLE 9 Asia Pacific q PCR Market by Country, 2021 - 2027, USD Million
  • TABLE 10 Asia Pacific Microarrays Market by Country, 2017 - 2020, USD Million
  • TABLE 11 Asia Pacific Microarrays Market by Country, 2021 - 2027, USD Million
  • TABLE 12 Asia Pacific Sequencing Technology Market by Country, 2017 - 2020, USD Million
  • TABLE 13 Asia Pacific Sequencing Technology Market by Country, 2021 - 2027, USD Million
  • TABLE 14 Asia Pacific Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 15 Asia Pacific Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 16 Asia Pacific Drug Discovery Market by Country, 2017 - 2020, USD Million
  • TABLE 17 Asia Pacific Drug Discovery Market by Country, 2021 - 2027, USD Million
  • TABLE 18 Asia Pacific Diagnostics & Disease Profiling Market by Country, 2017 - 2020, USD Million
  • TABLE 19 Asia Pacific Diagnostics & Disease Profiling Market by Country, 2021 - 2027, USD Million
  • TABLE 20 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
  • TABLE 21 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
  • TABLE 22 Asia Pacific Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 23 Asia Pacific Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 24 Asia Pacific CONSUMABLES MARKET by Country, 2017 - 2020, USD Million
  • TABLE 25 Asia Pacific CONSUMABLES MARKET by Country, 2021 - 2027, USD Million
  • TABLE 26 Asia Pacific INSTRUMENTS MARKET by Country, 2017 - 2020, USD Million
  • TABLE 27 Asia Pacific Instruments Market by Country, 2021 - 2027, USD Million
  • TABLE 28 Asia Pacific SOFTWARE MARKET by Country, 2017 - 2020, USD Million
  • TABLE 29 Asia Pacific SOFTWARE MARKET by Country, 2021 - 2027, USD Million
  • TABLE 30 Asia Pacific Services Market by Country, 2017 - 2020, USD Million
  • TABLE 31 Asia Pacific Services Market by Country, 2021 - 2027, USD Million
  • TABLE 32 Asia Pacific Transcriptomics Market by Country, 2017 - 2020, USD Million
  • TABLE 33 Asia Pacific Transcriptomics Market by Country, 2021 - 2027, USD Million
  • TABLE 34 China Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 35 China Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 36 China Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 37 China Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 38 China Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 39 China Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 40 China Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 41 China Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 42 Japan Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 43 Japan Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 44 Japan Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 45 Japan Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 46 Japan Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 47 Japan Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 48 Japan Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 49 Japan Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 50 India Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 51 India Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 52 India Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 53 India Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 54 India Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 55 India Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 56 India Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 57 India Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 58 South Korea Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 59 South Korea Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 60 South Korea Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 61 South Korea Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 62 South Korea Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 63 South Korea Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 64 South Korea Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 65 South Korea Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 66 Singapore Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 67 Singapore Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 68 Singapore Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 69 Singapore Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 70 Singapore Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 71 Singapore Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 72 Singapore Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 73 Singapore Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 74 Malaysia Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 75 Malaysia Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 76 Malaysia Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 77 Malaysia Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 78 Malaysia Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 79 Malaysia Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 80 Malaysia Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 81 Malaysia Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 82 Rest of Asia Pacific Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 83 Rest of Asia Pacific Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 84 Rest of Asia Pacific Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 85 Rest of Asia Pacific Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 86 Rest of Asia Pacific Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 87 Rest of Asia Pacific Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 88 Rest of Asia Pacific Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 89 Rest of Asia Pacific Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 90 Key Information - Fluidigm Corporation
  • TABLE 91 key Information - Promega Corporation
  • TABLE 92 Key Information - General Electric (GE) Co.
  • TABLE 93 KEY INFORMATION - MERCK & CO., INC.
  • TABLE 94 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 95 key information - Illumina, Inc.
  • TABLE 96 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 97 key Information - Agilent Technologies, Inc.
  • TABLE 98 key information - F. Hoffmann-La Roche Ltd.
  • TABLE 99 Key Information - Qiagen N.V.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
  • FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan - 2021, Apr) Leading Players
  • FIG 5 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar - 2021, Nov) Leading Players
  • FIG 6 Swot analysis: thermo fisher scientific, inc.
  • FIG 7 Recent strategies and developments: Bio-Rad Laboratories, Inc.
  • FIG 8 Recent strategies and developments: Qiagen N.V.